Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX)
$6.9100
-0.3500 ( -1.99% ) 8.3M
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Market Data
Open
$6.9100
Previous close
$7.2600
Volume
8.3M
Market cap
$2.73B
Day range
$6.7860 - $7.4690
52 week range
$5.6000 - $15.7400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 111 | Sep 03, 2024 |
4 | Insider transactions | 1 | Aug 30, 2024 |
4 | Insider transactions | 1 | Aug 29, 2024 |
8-k | 8K-related | 14 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 27, 2024 |
4 | Insider transactions | 1 | Aug 26, 2024 |
4 | Insider transactions | 1 | Aug 23, 2024 |
4 | Insider transactions | 1 | Aug 22, 2024 |
4 | Insider transactions | 1 | Aug 19, 2024 |